State Street’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Sell |
543,647
-42,570
| -7% | -$200K | ﹤0.01% | 3223 |
|
|
2025
Q1 | $2.14M | Buy |
586,217
+18,850
| +3% | +$68.8K | ﹤0.01% | 3220 |
|
|
2024
Q4 | $2.68M | Buy |
567,367
+61,422
| +12% | +$290K | ﹤0.01% | 3221 |
|
|
2024
Q3 | $4.71M | Buy |
505,945
+23,630
| +5% | +$220K | ﹤0.01% | 2999 |
|
|
2024
Q2 | $2.77M | Buy |
482,315
+44,651
| +10% | +$257K | ﹤0.01% | 3187 |
|
|
2024
Q1 | $2.94M | Buy |
437,664
+15,034
| +4% | +$101K | ﹤0.01% | 3143 |
|
|
2023
Q4 | $2.73M | Sell |
422,630
-11,240
| -3% | -$72.5K | ﹤0.01% | 3209 |
|
|
2023
Q3 | $2.17M | Sell |
433,870
-5,397
| -1% | -$27K | ﹤0.01% | 3293 |
|
|
2023
Q2 | $3.09M | Buy |
439,267
+29,754
| +7% | +$209K | ﹤0.01% | 3218 |
|
|
2023
Q1 | $2.54M | Buy |
409,513
+5,375
| +1% | +$33.3K | ﹤0.01% | 3259 |
|
|
2022
Q4 | $2.58M | Buy |
404,138
+32,520
| +9% | +$207K | ﹤0.01% | 3297 |
|
|
2022
Q3 | $3.19M | Buy |
371,618
+1,586
| +0.4% | +$13.6K | ﹤0.01% | 3270 |
|
|
2022
Q2 | $5.03M | Buy |
370,032
+51,807
| +16% | +$705K | ﹤0.01% | 3101 |
|
|
2022
Q1 | $4.85M | Buy |
318,225
+15,651
| +5% | +$238K | ﹤0.01% | 3195 |
|
|
2021
Q4 | $6.92M | Buy |
302,574
+77,554
| +34% | +$1.77M | ﹤0.01% | 3094 |
|
|
2021
Q3 | $3.14M | Buy |
225,020
+35,621
| +19% | +$496K | ﹤0.01% | 3480 |
|
|
2021
Q2 | $2.02M | Buy |
189,399
+80,300
| +74% | +$857K | ﹤0.01% | 3546 |
|
|
2021
Q1 | $1.44M | Buy |
109,099
+7,303
| +7% | +$96.3K | ﹤0.01% | 3545 |
|
|
2020
Q4 | $2.06M | Buy |
+101,796
| New | +$2.06M | ﹤0.01% | 3367 |
|